Description Module
The Description Module contains narrative descriptions of the clinical trial, including a brief summary and detailed description. These descriptions provide important information about the study's purpose, methodology, and key details in language accessible to both researchers and the general public.
Description Module path is as follows:
Study -> Protocol Section -> Description Module
Description Module
Ignite Creation Date:
2025-12-24 @ 7:38 PM
Ignite Modification Date:
2025-12-24 @ 7:38 PM
NCT ID:
NCT02259803
Brief Summary:
Study to investigate the relative bioavailability of fixed-dose combination tablet vs.
mono-components of telmisartan and amlodipine
Study:
NCT02259803
Study Brief:
Protocol Section:
NCT02259803